Infliximab Versus Adalimumab in Patients with Biologic-Naïve Crohn’s Disease: Is the Difference Real?
Crossref DOI link: https://doi.org/10.1007/s10620-018-4952-4
Published Online: 2018-02-08
Published Print: 2018-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mogilevski, Tamara
Sparrow, Miles P.
Text and Data Mining valid from 2018-02-08
Article History
First Online: 8 February 2018